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status, type of supplement plan, and residential location. RESULTS: Of the 2.2 million 
Medigap insureds eligible for the study, 25.4% (570,711) had CAD. Males were 60%
(p  0.001) more likely than females to have an ofﬁ ce visit, but gender was not a sig-
niﬁ cant predictor for the other services. Patients residing in high-minority neighbor-
hoods were about 8% (p  0.001) less likely to receive any services for CAD. Older 
individuals were signiﬁ cantly less likely (p  0.001) to have invasive procedures 
(angiography and surgery). Patients residing in lower-income areas were about 9% (p 
 0.001) more likely to receive any of the CAD services. Patients with mental health
problems were about 45% (p  0.001) less likely to receive any CAD services. Addi-
tionally, CAD-related care varied signiﬁ cantly by state of residence and urban versus 
rural location. Insureds with policies that covered more out-of-pocket costs were more 
likely to receive an ofﬁ ce visit, however, policy type was not a signiﬁ cant predictor for 
invasive CAD procedures. CONCLUSIONS: Disparities in CAD-related care existed 
by age, income, and race, but the magnitude was relatively small (about 10%). Larger 
disparities were found by residential location and for those with mental health prob-
lems. AARP and UnitedHealth Group are designing interventions to address these
disparities; such interventions will begin in mid-2009.
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OBJECTIVES: With generous coverage and patients’ full freedom to access different
tiers of medical facilities, Taiwan’s single payer national health insurance system is 
facing difﬁ culties of escalating utilization and cost of out-patient care. Recently, out-
patient co-payment has been largely increased in order to control unnecessary medical
demands and encourage patients with minor illness of initial contact in primary care,
but this policy has only shown limited impacts. To determine the relative importance 
of factors (attributes) associated with patients’ choices on accessing different tiers of 
medical facilities, we conducted a qualitative study on hypertensive outpatients.
METHODS: Focus groups were conducted on hypertensive outpatients from different 
tiers (clinics, local, regional hospitals and medical centers) of medical facilities in
Southern Taiwan. RESULTS: Nine focus groups were conducted at local community
(1), local hospital (2), regional hospital (2) and medical center (4), including 40 
hypertensive participants. The saturated opinions indicated doctors’ reputation and
friendliness, tiers of hospitals, and transportation convenience as the three main con-
siderations for participants to access different hospitals. Participants tend to visit a
ﬁ xed doctors and hospitals because they believe hypertension needs a long-term, con-
secutive and quality treatment. Higher-tier medical facilities are symbolized as better 
medical care, drugs and equipments, yet the out-of-pocket payment is considered
affordable, especially doctors prescribed continuous prescriptions to save patient’s
co-payment charge. Participants dislike being transferred from lower to higher tiers
of medical facilities due to the inconvenient process and lack of price incentive. 
CONCLUSIONS: By identifying attributes to hypertensive outpatients’ choices of 
accessing medical facilities, we found the current co-payment policy does not impact 
on hypertensive patients’ affordability and accessibility in Southern Taiwan. Future
study is going to determine the relative importance of attributes and whether and how
much higher co-payment charge can inﬂ uence on patients’ decisions to access different
tiers of medical facilities.
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OBJECTIVES: Top describe the tendency of cardiovascular risk and the determining 
factors of a cohort of patients enrolled in the De todo corazón disease management 
(DM) programme. METHODS: The DTC programme was begun in Colombia in
2004 and 19,697 patients have beneﬁ tted up to December 2007; it seeks to control 
cardiovascular risk (CVR) using a DM model. The present study represents a ﬁ rst 
approach to evaluate the programme’s effectiveness by analysing the tendency of CVR 
marker variables, such as blood-pressure and lipid proﬁ le by CVR group. The popula-
tion being studied consisted of patients who had formed part of the programme since
2004 and who had uninterrupted annual follow-up visits up to 2007. A descriptive
analysis was made, annual CVR level was calculated using the methodology described 
by ATPIII and tendency was described by both variables and CVR groups. RESULTS:
Average age for the ﬁ nal population to be analysed (5174) was 63.74 years (11.76 
S.D) and mainly consisted of females (72%). A decreasing tendency in the high risk 
group was observed in analysis by CVR group, accompanied by a corresponding
increase in patients classiﬁ ed in latent and intermediate levels. Similarly, analysing 
tendency by variable revealed how systolic blood-pressure tended to decrease consis-
tently throughout the time spent on each visit in each risk group. LDL-cholesterol
revealed a similar tendency in high and intermediate risk groups, less stable behaviour
being seen in the latent risk group. HDL-cholesterol presented stable tendency in the 
three risk groups during successive visits. CONCLUSIONS: The results suggested that 
the De todo corazón DM programme had a positive impact during the period being 
studied, affecting modiﬁ able risk factors such as TA and lipid proﬁ le and CVR control. 
Such tendencies should be compared with a control group for establishing whether 
they have really been produced by the DM programme.
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OBJECTIVES: This study compared hypertension management in newly treated and
previously treated (established) adult patients (q18 years) with hypertension. 
METHODS: A retrospective study was conducted using the GE Centricity electronic 
medical record database which contains ambulatory electronic health record data for 
over 7.4 million patients in the US. Patients were classiﬁ ed as newly treated hyperten-
sives if they had no antihypertensive treatment within 24 months prior to the index 
date (date of the ﬁ rst anti-hypertensive prescription in 2006). Otherwise, patients were 
classiﬁ ed as established hypertensives if they received antihypertensive treatment
during 24 months prior to index date. These two groups were compared to assess 
differences in comorbid conditions, proportion of patients treated per JNC-7 guide-
lines, distribution of index drugs, likelihood of achieving BP goal and changes in the 
antihypertensive therapy during 13 months follow-up period from the index date. 
RESULTS: A total of 28,276 newly treated patients (mean age 58.6 years; 55.7% 
women) and 78,450 (62.1 years; 57.1% women) established patients were identiﬁ ed. 
Newly diagnosed patients had fewer comorbidities (mean number 0.74 vs. 1.85; p 
0.001), less changes in anti-hypertensive medications (1.6 vs. 1.7; p  0.001), less 
likely to be treated per JNC-7 guideline (52.7% vs. 60.2%; p  0.001), and more
likely to be treated on monotherapy at index (66.2% vs. 39.9%; p  0.001) than 
established patients. Among the newly diagnosed patients, ACE inhibitors (ACEi) 
(30.6%) and diuretics (19.2%) were the most commonly prescribed ﬁ rst-line treat-
ments, while ACEi (22.3%) and the combination of ACEi and diuretics (9.2%) were 
more commonly prescribed in the established patients. After controlling for age,
gender, race, comorbid conditions, baseline BP, adherence to JNC-7, newly diagnosed
patients were 38% more likely to achieve BP goal at follow-up (p  0.001). CONCLU-
SIONS: Newly treated hypertensive patients tend to be younger, with less comorbidi-
ties, more likely to be treated on monotherapy and achieve BP goal compared with 
established patients.
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OBJECTIVES: Elevated warfarin levels caused by drug-drug interactions (DDIs) 
increase the risk of gastrointestinal bleeding and vascular accidents. Electronic medical 
records (EMRs) have been associated with a greater potential for identifying DDIs.
We evaluated the inﬂ uence of EMR use on trends in prescribing potentially harmful
drug combinations involving warfarin from a nationwide survey of ambulatory care 
ofﬁ ce visits. METHODS: Data were derived from the 2003–2006 National Ambula-
tory Medical Care Survey (NAMCS), a public-use, nationwide probability sample 
survey of ofﬁ ce visits by ambulatory patients to non-Federally employed physicians. 
Warfarin and interacting drugs prescribed within the same visit were identiﬁ ed. We 
evaluated the proportion of interaction-related encounters comparing visits with and
without the availability of EMRs. Subgroup analyses were performed by combining
2-years of data (2003–2004 and 2005–2006) for more precise estimates. All analyses
were weighted to reﬂ ect the sampling design of NAMCS to reﬂ ect representative 
ambulatory care use in the U.S. with appropriate variances. RESULTS: Total warfarin-
related visits increased from 11.8 million in 2003 to 16.6 and 15.4 million in 2005 
and 2006, respectively. In 2003–2004 (period 1) the proportion of warfarin visits in 
which an interacting drug was co-prescribed was 34.4% (95% CI: 21.4%–47.4%) 
with EMRs available and 32.0% (95% CI: 27.5%–36.5%) with no EMRs available. 
In 2005–2006 (period 2), the proportions were 36.7% (30.9%–42.4%) with EMRs 
and 33.5% (28.6%–38.3%) without EMRs. We observed no signiﬁ cant differences in 
the proportions of interaction-related encounters between EMR and non-EMR visits 
in both periods. CONCLUSIONS: Between 2003 and 2006, the rates of warfarin
prescribing in ambulatory care increased by 27%. The proportions of interaction-
related encounters were unaffected by EMR use, due possibly to the limited imple-
mentation of EMRs during that period. Further studies as newer data become available
are needed.
